We are live on ! Find out more
Engaged Capital

Engaged Capital Portfolio holdings

AUM $283M Turnover 27.27%
1-Year Est. Return 1.72%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
-1.72%
3 Year Est. Return
+13.2%
5 Year Est. Return
+29.42%
10 Year Est. Return
+321.41%
AUM
$795M
AUM Growth
+$58M
Cap. Flow
+$14.5M
Cap. Flow %
1.82%
Top 10 Hldgs %
95.36%
Holding
19
New
4
Increased
6
Reduced
1
Closed
3
Avg Time Held
1.3 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.3 years

Sector Composition

Rank Sector Weight
1 Consumer Staples 51.35%
2 Technology 26.51%
3 Industrials 14.76%
4 Consumer Discretionary 4.28%
5 Healthcare 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HAIN icon
1
Hain Celestial
HAIN
$9.6M
$350M 44.1%
11,761,242
– –
2017 Q1
5 quarters
UPBD icon
2
Upbound Group
UPBD
$1.45B
$132M 16.64%
8,983,609
– –
2016 Q4
6 quarters
APOG icon
3
Apogee Enterprises
APOG
$971M
$71.8M 9.04%
1,491,020
+492,086
+49% +$21.1M
2017 Q4
2 quarters
STKL
4
DELISTED
SunOpta
STKL
$57.6M 7.25%
6,856,907
+100,000
+1% +$756K
2016 Q2
8 quarters
BHE icon
5
Benchmark Electronics
BHE
$2.19B
$39.8M 5.01%
1,366,874
+274,164
+25% +$7.87M
2015 Q1
13 quarters
TIVO
6
DELISTED
TiVo
TIVO
$34M 4.27%
2,525,000
– –
2013 Q4
18 quarters
JMBA
7
DELISTED
Jamba
JMBA
$30.2M 3.8%
2,834,002
– –
2014 Q2
16 quarters
CLS icon
8
Celestica
CLS
$29.8B
$19.6M 2.47%
1,652,439
– –
2017 Q3
3 quarters
BW icon
9
Babcock & Wilcox
BW
$637M
$11.5M 1.45%
482,854
+347,021
+255% +$9.22M
2017 Q4
2 quarters
VYX icon
10
NCR Voyix
VYX
$1.33B
$10.7M 1.34%
579,952
+186,871
+48% +$3.53M
2017 Q3
3 quarters
PETX
11
DELISTED
Aratana Therapeutics
PETX
$10.2M 1.28%
2,400,000
+400,000
+20% +$2.02M
2018 Q1
1 quarter
ANIK icon
12
Anika Therapeutics
ANIK
$173M
$8.4M 1.06%
+262,547
New +$10.8M
2018 Q2
0 quarters
UEIC icon
13
Universal Electronics
UEIC
$77.8M
$8.32M 1.05%
+251,676
New +$9.45M
2018 Q2
0 quarters
CASY icon
14
Casey's General Stores
CASY
$26.1B
$3.85M 0.48%
+36,672
New +$3.71M
2018 Q2
0 quarters
GRPN icon
15
Groupon
GRPN
$472M
$3.73M 0.47%
+43,406
New +$4.03M
2018 Q2
0 quarters
CCRN icon
16
DELISTED
Cross Country Healthcare
CCRN
$2.34M 0.29%
207,680
-283,989
-58% -$3.39M
2017 Q2
4 quarters
IWM icon
17
iShares Russell 2000 ETF
IWM
$74B
– –
-21,000
Closed -$3.19M –
MX icon
18
Magnachip Semiconductor
MX
$89.4M
– –
-1,181,225
Closed -$11.3M –
FNSR
19
DELISTED
Finisar
FNSR
– –
-2,538,126
Closed -$40.1M –

Similar funds

Engaged Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Engaged Capital held 19 positions worth $795M, up 7.9% from $737M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Engaged Capital's Q2 2018 filing shows 4 new, 6 increased, 1 reduced and 3 closed positions. Its largest new stake was Anika Therapeutics: 262,547 shares worth $8.4M. The largest sale was Finisar, an estimated $40.1M.

By sector, the portfolio is most concentrated in Consumer Staples at 51% of assets, down from 58% a quarter earlier, followed by Technology and Industrials.

  • Engaged Capital's largest Q2 2018 buy was Anika Therapeutics: 262,547 shares worth $8.4M.
  • Engaged Capital added most to Apogee Enterprises in Q2 2018, an estimated $21.1M increase.
  • Engaged Capital's biggest Q2 2018 reduction was Cross Country Healthcare, cutting an estimated $3.39M.
  • Engaged Capital fully exited Finisar in Q2 2018, selling an estimated $40.1M.
  • Engaged Capital's ten largest holdings make up 95% of its $795M portfolio in Q2 2018.
  • Engaged Capital opened 4 new positions and closed 3 in Q2 2018.
  • Engaged Capital's portfolio value rose 7.9% quarter-over-quarter to $795M.

Based on Engaged Capital's 13F filing for Q2 2018, filed 14 Aug 2018.